Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
DESIGN AND DEVELOPMENT OF LIGAND ASSOCIATED SORAFENIB TOSYLATE NANOPARTICLES FOR LIVER CANCER
International Journal of Applied Pharmaceutics
Sep-Oct 2026
Vishene S.S.
Open Access
Silibinin Triggers Mitochondrial Apoptosis and Declines Clonogenic Potential in Detroit 562 Human Pharyngeal Carcinoma Cells
Medicina Lithuania
December 2025
Talpos S.
Open Access
Synergistic Anticancer Effects of Silibinin and Sulforaphane: Targeting Gastric Cancer via PI3K/AKT and ERK1/2 MAPK Pathway Inhibition and Molecular Docking Insights
Journal of Biochemical and Molecular Toxicology
April 2025
Liu Y.
Anti-glycating and anti-cytotoxic effect of silibinin on albumin at early glycation: A physiochemical study
Archives of Biochemistry and Biophysics
March 2024
Neelofar K.
Open Access
A New Glucosyl Flavone with Inhibitory Activity of Cancer Cell Viability and Other Bioactive Constituents from the Traditional Kurdish Plant Plantago loeflingii L.
Molecules
March 2024
Amin H.I.M.
Open Access
A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment
Frontiers in Pharmacology
2024
Ray P.P.
Open Access
Silymarin inhibits the lipogenic pathway and reduces worsening of non-alcoholic fatty liver disease (NAFLD) in mice
Archives of Physiology and Biochemistry
2024
Carvalho L.C.F.
Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders
Drug Design Development and Therapy
2024
Selc M.
Open Access
Functional bioinspired nanocomposites for anticancer activity with generation of reactive oxygen species
Chemosphere
January 2023
Khalid A.D.
Open Access
Natural Blockers of PD-1/PD-L1 Interaction for the Immunotherapy of Triple-Negative Breast Cancer-Brain Metastasis
Cancers
December 2022
Nakhjavani M.
Open Access
Diallyl Disulfide Induces Chemosensitization to Sorafenib, Autophagy, and Cell Cycle Arrest and Inhibits Invasion in Hepatocellular Carcinoma
Pharmaceutics
December 2022
Machado A.R.T.
Open Access
The hepatoprotective effect of silibinin after hepatic ischemia/reperfusion in a rat model is confirmed by immunohistochemistry and qRT-PCR
Journal of Pharmacy and Pharmacology
1 September 2021
Betsou A.
The safety, efficacy and pharmaceutical quality of male enhancement nutraceuticals bought online: Truth versus claim
Journal of Integrative Medicine
May 2021
Nounou M.I.
In-vitro evaluation of antiproliferative potential of various fractions of Silybum marianum using HeLa and HepG2 cell lines
Pakistan Journal of Pharmaceutical Sciences
March 2021
Nawaz A.
Open Access
Collagen Nanoparticle-Mediated Brain Silymarin Delivery: An Approach for Treating Cerebral Ischemia and Reperfusion-Induced Brain Injury
Frontiers in Neuroscience
26 October 2020
Rathore P.
Open Access
Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism
Archives of Biochemistry and Biophysics
15 September 2020
Sellam L.S.
All Open Access, Green
Two new phenolic glycosides from the seeds of Citrullus lanatus
Natural Product Research
1 February 2020
Zhang X.Q.
Cytotoxic effects of hydroxy coumarin derivatives on mouse neuroblastoma n2a cell line
Iranian Journal of Pharmaceutical Sciences
2020
Sargolzaei J.
Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells
ACS Omega
13 May 2019
Mirzaaghaei S.
Open Access
Gene Ontology and Expression Studies of Strigolactone Analogues on a Hepatocellular Carcinoma Cell Line
Analytical Cellular Pathology
2019
Hasan M.N.
Open Access
Preliminary studies of the cytotoxicity and photoprotective properties of benzophenone and lactone derivatives
Revista Virtual De Quimica
May-June 2018
Gonçalves M.C.
Open Access